JP2015519307A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519307A5
JP2015519307A5 JP2015504725A JP2015504725A JP2015519307A5 JP 2015519307 A5 JP2015519307 A5 JP 2015519307A5 JP 2015504725 A JP2015504725 A JP 2015504725A JP 2015504725 A JP2015504725 A JP 2015504725A JP 2015519307 A5 JP2015519307 A5 JP 2015519307A5
Authority
JP
Japan
Prior art keywords
compound
amino
ylamino
fluoro
dimethyloctahydroindolizin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015504725A
Other languages
English (en)
Japanese (ja)
Other versions
JP6113828B2 (ja
JP2015519307A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/035285 external-priority patent/WO2013152198A1/en
Publication of JP2015519307A publication Critical patent/JP2015519307A/ja
Publication of JP2015519307A5 publication Critical patent/JP2015519307A5/ja
Application granted granted Critical
Publication of JP6113828B2 publication Critical patent/JP6113828B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015504725A 2012-04-04 2013-04-04 プロテインキナーゼc阻害剤およびその使用 Expired - Fee Related JP6113828B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261620232P 2012-04-04 2012-04-04
US61/620,232 2012-04-04
US201361783647P 2013-03-14 2013-03-14
US61/783,647 2013-03-14
PCT/US2013/035285 WO2013152198A1 (en) 2012-04-04 2013-04-04 Protein kinase c inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2015519307A JP2015519307A (ja) 2015-07-09
JP2015519307A5 true JP2015519307A5 (enExample) 2016-06-02
JP6113828B2 JP6113828B2 (ja) 2017-04-12

Family

ID=49301046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015504725A Expired - Fee Related JP6113828B2 (ja) 2012-04-04 2013-04-04 プロテインキナーゼc阻害剤およびその使用

Country Status (6)

Country Link
US (3) US9321763B2 (enExample)
EP (1) EP2833889B1 (enExample)
JP (1) JP6113828B2 (enExample)
CA (1) CA2867760C (enExample)
ES (1) ES2658395T3 (enExample)
WO (1) WO2013152198A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9321763B2 (en) 2012-04-04 2016-04-26 Rigel Pharmaceuticals, Inc. Protein kinase C inhibitors and uses thereof
US9169249B2 (en) 2013-03-14 2015-10-27 Rigel Pharmaceuticals, Inc. Protein kinase C inhibitors and uses thereof
HUE046727T2 (hu) * 2013-12-06 2020-03-30 Vertex Pharma Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
BR112016017444A2 (pt) * 2014-01-29 2017-10-10 Inst Nat Sante Rech Med molécula e método
NZ715903A (en) 2014-01-30 2017-06-30 Signal Pharm Llc Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
US9399637B2 (en) 2014-03-28 2016-07-26 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
US10059689B2 (en) 2014-10-14 2018-08-28 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
WO2017007755A1 (en) 2015-07-06 2017-01-12 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
HUE057041T2 (hu) 2015-07-06 2022-04-28 Alkermes Inc Hiszton deacetiláz hetero-halogén gátlói
EP3347097B1 (en) 2015-09-11 2021-02-24 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora
HRP20220223T1 (hr) 2017-01-11 2022-04-29 Alkermes, Inc. Biciklički inhibitori histon deacetilaze
EP3421485A1 (en) 2017-06-30 2019-01-02 Université de Strasbourg Peptides for treatment and prevention of hyperglycaemia
US11225475B2 (en) 2017-08-07 2022-01-18 Alkermes, Inc. Substituted pyridines as inhibitors of histone deacetylase
WO2019099311A1 (en) 2017-11-19 2019-05-23 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use
JP2024513227A (ja) 2021-04-05 2024-03-22 ハリア・セラピューティクス・インコーポレイテッド Nek7阻害剤
WO2022226182A1 (en) 2021-04-22 2022-10-27 Halia Therapeutics, Inc. Nek7 inhibitors
JPWO2024122617A1 (enExample) 2022-12-08 2024-06-13

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843935A (en) 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
EA017937B1 (ru) * 2007-02-07 2013-04-30 Пфайзер Инк. ПРОИЗВОДНЫЕ 3-АМИНОПИРРОЛО[3,4-c]ПИРАЗОЛ-5(1H,4H,6H)-КАРБАЛЬДЕГИДА В КАЧЕСТВЕ ИНГИБИТОРОВ РКС
CN101903357A (zh) * 2007-07-17 2010-12-01 里格尔药品股份有限公司 作为pkc抑制剂的环状胺取代的嘧啶二胺
CN102292333B (zh) 2009-01-15 2015-05-13 里格尔药品股份有限公司 蛋白激酶c抑制剂及其用途
WO2010090875A1 (en) 2009-01-21 2010-08-12 Rigel Pharmaceuticals, Inc. Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
US20110130415A1 (en) 2009-12-01 2011-06-02 Rajinder Singh Protein kinase c inhibitors and uses thereof
CA2801781C (en) * 2010-07-21 2018-02-27 Rigel Pharmaceuticals, Inc. Protein kinase c inhibitors and uses thereof
KR101937495B1 (ko) 2010-07-28 2019-01-10 리겔 파마슈티칼스, 인크. Jak 경로의 억제를 위한 조성물 및 방법
US9321763B2 (en) * 2012-04-04 2016-04-26 Rigel Pharmaceuticals, Inc. Protein kinase C inhibitors and uses thereof
US9169249B2 (en) * 2013-03-14 2015-10-27 Rigel Pharmaceuticals, Inc. Protein kinase C inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
RU2014124950A (ru) Производные 2-фениламинопиримидина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2) для лечения болезни паркинсона
IL279728B1 (en) Modified naphthyridinone compounds useful as t-cell activators
RU2014152257A (ru) Гетероциклильные пиримидиновые аналоги в качестве ингибиторов tyk2
RU2014124953A (ru) Производные аминопиридина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2)
RU2398769C2 (ru) Азотосодержащие гетеробициклические соединения
AU2005229331B2 (en) Diaminopyrimidines as P2X3 and P2X2/3 antagonists
RU2014124639A (ru) Производные 2-(фенил или пирид-3-ил)аминопиримидина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2) для лечения болезни паркинсона
RU2014125211A (ru) Фтор-18 и углерод-11 меченые радиолиганды для томографии с позитронной эмиссией (рет), визуализирующей lrrk2
JP2021529191A5 (enExample)
HRP20191220T1 (hr) Disupstituirani oktahi-dropirolo[3,4-c]piroli kao modulatori oreksin receptora
DK2922848T3 (da) Oxazolidin-2-on-pyrimidinderivater
NZ594606A (en) Fused ring compound and use thereof
RU2015112580A (ru) Ингибиторные соединения
RU2014124640A (ru) Производные аминопиримидина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2)
PE20221517A1 (es) Derivado de triazolopiridazina, metodo de preparacion del mismo, composicion farmaceutica del mismo y uso del mismo
PE20191528A1 (es) Nuevos derivados de triazolo[4,5-d]pirimidina
PE20080545A1 (es) Isoxazolinas insecticidas
UY35979A (es) Procedimiento para la preparación de compuestos de aminocrotonilo
RU2017135520A (ru) Бициклические производные хиназолинона
UY29835A1 (es) Formas de dosificación farmacéutica sólidas que comprenden 5-cloro-n-(((5s)-2-oxo-3-(4-(3-oxo-4-morfolinil)fenil)-1,3-oxazolidin-5-il)metil)-2-tiofenocarboxamida
RU2015132181A (ru) Фтор-[1,3]-оксазины в качестве ингибиторов васе1
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
CR9863A (es) Nueva formula polimorfica y la forma amorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il)- metil)-2-tiofenocarboxamida
PE20081228A1 (es) Compuesto heteromonociclico
JP2014523400A5 (enExample)